162 related articles for article (PubMed ID: 7737638)
1. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club.
Primignani M; Andreoni B; Carpinelli L; Capria A; Rocchi G; Lorenzini I; Staudacher C; Beretta L; Motta R; de Franchis R
Hepatology; 1995 May; 21(5):1322-7. PubMed ID: 7737638
[TBL] [Abstract][Full Text] [Related]
2. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis.
Zuberi BF; Baloch Q
Am J Gastroenterol; 2000 Mar; 95(3):768-71. PubMed ID: 10710072
[TBL] [Abstract][Full Text] [Related]
3. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.
Masci E; Stigliano R; Mariani A; Bertoni G; Baroncini D; Cennamo V; Micheletti G; Casetti T; Tansini P; Buscarini E; Ranzato R; Norberto L
Hepatogastroenterology; 1999; 46(27):1769-73. PubMed ID: 10430341
[TBL] [Abstract][Full Text] [Related]
4. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial.
Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA
Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259
[TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy with or without octreotide for acute variceal bleeding.
Besson I; Ingrand P; Person B; Boutroux D; Heresbach D; Bernard P; Hochain P; Larricq J; Gourlaouen A; Ribard D
N Engl J Med; 1995 Aug; 333(9):555-60. PubMed ID: 7623904
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage.
Shah HA; Mumtaz K; Jafri W; Abid S; Hamid S; Ahmad A; Abbas Z
J Ayub Med Coll Abbottabad; 2005; 17(1):10-4. PubMed ID: 15929518
[TBL] [Abstract][Full Text] [Related]
8. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.
D'Amico G; Politi F; Morabito A; D'Antoni A; Guerrera D; Giannuoli G; Traina M; Vizzini G; Pasta L; Pagliaro L
Hepatology; 1998 Nov; 28(5):1206-14. PubMed ID: 9794903
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
[TBL] [Abstract][Full Text] [Related]
10. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: a prospective, randomized trial.
Lo GH; Lai KH; Cheng JS; Lin CK; Huang JS; Hsu PI; Huang HC; Chiang HT
Hepatology; 1998 Aug; 28(2):391-5. PubMed ID: 9696002
[TBL] [Abstract][Full Text] [Related]
11. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
[TBL] [Abstract][Full Text] [Related]
12. Octreotide in acute bleeding esophageal varices: a prospective randomized study.
Freitas DS; Sofia C; Pontes JM; Gregório C; Cabral JP; Andrade P; Rosa A; Camacho E; Ferreira M; Portela F; Romãozinho JM; Tomé L; Gouveia H; Leitão M; Pimenta I; Donato A
Hepatogastroenterology; 2000; 47(35):1310-4. PubMed ID: 11100339
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
[TBL] [Abstract][Full Text] [Related]
14. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.
Escorsell A; Ruiz del Arbol L; Planas R; Albillos A; Bañares R; Calès P; Pateron D; Bernard B; Vinel JP; Bosch J
Hepatology; 2000 Sep; 32(3):471-6. PubMed ID: 10960437
[TBL] [Abstract][Full Text] [Related]
15. [Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].
Villanueva C; Martínez FJ; Torras X; Sáinz S; Soriano G; González D; Balanzó J
Rev Esp Enferm Dig; 1994 Jul; 86(1):499-504. PubMed ID: 7917561
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.
García-Villarreal L; Martínez-Lagares F; Sierra A; Guevara C; Marrero JM; Jiménez E; Monescillo A; Hernández-Cabrero T; Alonso JM; Fuentes R
Hepatology; 1999 Jan; 29(1):27-32. PubMed ID: 9862845
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
[TBL] [Abstract][Full Text] [Related]
18. Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group.
Hepatology; 1994 Sep; 20(3):618-25. PubMed ID: 8076919
[TBL] [Abstract][Full Text] [Related]
19. What is the aim of esophageal variceal sclerotherapy--prevention of rebleeding or complete obliteration of veins?
Parikh SS; Desai HG
J Clin Gastroenterol; 1992 Oct; 15(3):186-8. PubMed ID: 1342583
[TBL] [Abstract][Full Text] [Related]
20. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
de la Peña J; Brullet E; Sanchez-Hernández E; Rivero M; Vergara M; Martin-Lorente JL; Garcia Suárez C
Hepatology; 2005 Mar; 41(3):572-8. PubMed ID: 15726659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
